Infectious Disease Therapeutics
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$21.4M
7 rounds on record
Latest round
$1.9M
Convertible Note · Dec 2021 · 4 yr ago
Team
51-200
employees, estimated range
Grants
$2.1M
4 grants · CORDIS
Backers
1
Port Folia
The money's age
Long since its last round
57 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 28, 2023
Recognition OtoNexus Medical Technologies Honored as a Top 100 Best Place to Work in Washington State · counton2.com
Apr 4, 2023
Board appointment OtoNexus Medical Technologies Welcomes Chris Rivera to its Board of Directors · PRNewswire
Oct 20, 2022
Took on debt financing $12.9M · SEC Form D
Dec 30, 2021
Raised a round Convertible Note $1.9M · SEC Form D
Mar 15, 2019
Won a grant $718k · CORDIS
Jul 1, 2017
Won a grant $999k · CORDIS
Jul 1, 2017
Won a grant $225k · CORDIS
Sep 1, 2016
Won a grant $148k · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Debt Financing | Oct 2022 | $12.9M | — | SEC Form D |
| Convertible Note | Dec 2021 | $1.9M | — | SEC Form D |
| Grant | Mar 2019 | $718k | — | CORDIS |
| Venture round | Dec 2018 | $19.5M | — | SEC Form D |
| Grant | Jul 2017 | $225k | — | CORDIS |
| Grant | Jul 2017 | $999k | — | CORDIS |
| Grant | Sep 2016 | $148k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | OtoNexus Medical Technologies, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Caitlin CameronExecutive Officer, DirectorSEC Form D
George GatesExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Arrowsmith Inc. is a research-driven biotech focused on bringing next-generation phage therapy into clinical use for patients suffering…

Our Mission and Innovation We are a biotechnology pioneer dedicated to solving one of the greatest challenges in modern medicine: the…

Welcome to Resistell, where we harness cutting-edge nanomotion technology to provide the fastest, most accurate ultra-rapid antibiotic…

Smartbax is dedicated to developing innovative antibiotics to combat the rising threat of multi-drug-resistant bacteria and protect global…

Gamgee is developing personalised mRNA vaccines as a cancer treatment for dogs, built from each dog’s tumour. See how it works with vets…

Procarta Biosystems Ltd aims to revolutionise the treatment of serious and life-threatening infection through the development of innovative…
News
OtoNexus Medical Technologies Ranks #4 Among Micro Companies on Puget Sound Business Journal
OtoNexus Medical Technologies has been named to Puget Sound Business Journal
Read more
Report
OtoNexus Medical Technologies Accepted into Prestigious Pediatric Medical Device Accelerator, CTIP
/PRNewswire/ -- OtoNexus Medical Technologies Inc., the innovators behind the first ultrasound-based medical device for the instant, accurate assessment of...
Read more
Report
Report
OtoNexus Medical Technologies Welcomes Chris Rivera to its Board of Directors
/PRNewswire/ -- OtoNexus Medical Technologies, Inc. is pleased to announce the appointment of Chris Rivera to its Board of Directors. Mr. Rivera has a...
Read more
Report
SNS FiRe Conference Names OtoNexus Medical Technologies a 2016 FiReStarter Company
Strategic News Service has selected OtoNexus Medical Technologies as a 2016 FiReStarter company to be featured at the 14th annual Future in Review conference. FiRe 2016 will take place September 27-30, ...
Read more
Report
Puget Sound Business Journal
OtoNexus Medical Technologies is honored to have received awards and recognition from Keiretsu Capital (Most Valued Company), Keiretsu Forum MidAtlantic (Most Valued Company), Keiretsu Forum Northwest (Most Valued Company), Red Herring (Top 100 North Amer
Read more
Report
People

Caitlin Cameron
Executive Officer, Director

George Gates
Executive Officer, Director

Harris Brody
Director

Marion Foote
Director

Mark Moehring
Director

Rhonda Rhyne
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Bellevue
United States
HQ
50-200 est. staff
Financials
Total raised
$36.4M
Latest round
Debt Financing
Funding rounds
7

Port Folia 




